- Home
- CNTX vs USAS Comparison
CNTX vs USAS Comparison
Compare CNTX & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- USAS
- Stock Information
- Founded
- CNTX 2015
- USAS 1998
- Country
- CNTX United States
- USAS Canada
- Employees
- CNTX N/A
- USAS N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- USAS Metal Mining
- Sector
- CNTX Health Care
- USAS Basic Materials
- Exchange
- CNTX Nasdaq
- USAS Nasdaq
- Market Cap
- CNTX 149.6M
- USAS 122.4M
- IPO Year
- CNTX 2021
- USAS N/A
- Fundamental
- Price
- CNTX $1.30
- USAS $0.39
- Analyst Decision
- CNTX Strong Buy
- USAS Strong Buy
- Analyst Count
- CNTX 3
- USAS 1
- Target Price
- CNTX $6.83
- USAS $0.80
- AVG Volume (30 Days)
- CNTX 210.1K
- USAS 1.5M
- Earning Date
- CNTX 11-06-2024
- USAS 11-07-2024
- Dividend Yield
- CNTX N/A
- USAS N/A
- EPS Growth
- CNTX N/A
- USAS N/A
- EPS
- CNTX N/A
- USAS N/A
- Revenue
- CNTX N/A
- USAS $97,123,000.00
- Revenue This Year
- CNTX N/A
- USAS $25.05
- Revenue Next Year
- CNTX N/A
- USAS $35.97
- P/E Ratio
- CNTX N/A
- USAS N/A
- Revenue Growth
- CNTX N/A
- USAS 14.33
- 52 Week Low
- CNTX $0.77
- USAS $0.20
- 52 Week High
- CNTX $2.75
- USAS $0.54
- Technical
- Relative Strength Index (RSI)
- CNTX 25.94
- USAS 45.06
- Support Level
- CNTX $1.56
- USAS $0.36
- Resistance Level
- CNTX $2.32
- USAS $0.42
- Average True Range (ATR)
- CNTX 0.16
- USAS 0.04
- MACD
- CNTX -0.07
- USAS -0.01
- Stochastic Oscillator
- CNTX 17.88
- USAS 46.08
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.